Jan Smilek, John Quackenbush, Bob Carter, Carlos Cordon-Cardo, Keith Flaherty
Akonni Biosystems appoints Jan Smilek as CFO; James Robb joins Biomatrica's SAB.
The companies plan to combine Akonni's TruArray gel-drop microarray platform with Seegene's Dual Priming Oligo multiplex PCR technology in a bid to deliver a low-cost molecular diagnostics system.
The firms will combine their technologies to develop molecular diagnostic tests for infectious pathogens that cause respiratory diseases.
The agreement provides Akonni access to nucleic acid sequences, primers, and probes for several important biothreat agents, which it will incorporate into molecular tests on its TruArray and TruSentry platforms.
Akonni plans to use the content to develop products to expand its market presence beyond detection of infectious diseases, including global biosecurity.
RainDance's DeepSeq FFPE solution, Akonni Biosystems' TruSentry system; and New England Biolabs' NEBNext Small RNA Sample Prep Set 1 and 3.
Akonni's TruTip genomic DNA extraction kit; Promega's ReliaPrep Blood and Tissue gDNA miniprep systems.
NSF Microarray Grants Awarded Aug. 1, 2010 — Jan. 1, 2011
Akonni will evaluate a method of manufacturing microarrays that it believes could lower the cost of array-based molecular diagnostic testing.
23andMe and Airbnb have partnered to offer "heritage travel," according to Venture Beat.
China may include regulations protecting genes and embryos in its update of its civil code, Nature News reports.
In Nature this week: exome sequence analysis of individuals with type 2 diabetes, genomic prediction of maize yield across environments, and more.
NPR reports on efforts to engineer bacteriophages to destroy antibiotic-resistance bacteria.